Remission of refractory esophageal lichen planus induced by tofacitinib
Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · 1384-1388
DOI: 10.1055/a-2300-0375 ↗Kurz gefasst
Fallbericht in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von Valentina Bieneck und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Lichen Planus, Piperidines, Pyrimidines, Pyrroles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
As of now, there exists no established therapy for ELP. Retinoids, which are standard in treating cutaneous LP, do not exhibit positive effects in ELP. While topical glucocorticosteroids often yield favorable responses in esophageal inflammation, some cases prove recalcitrant or refractory. In such instances, various immunosuppressive therapies have been attempted with variable success. This report details a severe case of ELP that showed resistance to prednisolone, acitretin, alitretinoin, adalimumab, tacrolimus, hydroxychloroquine plus mycophenolate mofetil, and cyclophosphamide. The initiation of the JAK inhibitor tofacitinib induced an impressive clinical, endoscopic, and histological remission. This positive response to a JAK inhibitor is discussed in the context of our evolving understanding of the immune-mediated pathogenesis of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, Medical Center, University of Freiburg, Freiburg, Germany.
- University of Freiburg Faculty of Medicine, Freiburg, Germany.
ORCID-Profile: Annegrit Decker, Annette Schmitt-Graeff, Wolfgang Kreisel, Franziska Schauer
Zitieren
APA
Bieneck, V., Decker, A., Schmitt-Graeff, A., Kreisel, W., & Schauer, F. (2024). Remission of refractory esophageal lichen planus induced by tofacitinib. Zeitschrift für Gastroenterologie, 62(09), 1384-1388. https://doi.org/10.1055/a-2300-0375
Vancouver
Bieneck V, Decker A, Schmitt-Graeff A, Kreisel W, Schauer F. Remission of refractory esophageal lichen planus induced by tofacitinib. Zeitschrift für Gastroenterologie. 2024;62(09):1384-1388. doi:10.1055/a-2300-0375
BibTeX
@article{Bieneck2024,
author = {Bieneck, Valentina and Decker, Annegrit and Schmitt-Graeff, Annette and Kreisel, Wolfgang and Schauer, Franziska},
title = {Remission of refractory esophageal lichen planus induced by tofacitinib},
journal = {Zeitschrift für Gastroenterologie},
year = {2024},
volume = {62},
number = {09},
pages = {1384--1388},
doi = {10.1055/a-2300-0375}
}
EUVIMED